Amphenol Corporation stock jumps 8% as CEO set to become chairman; dividend date looms

Amphenol Corporation stock jumps 8% as CEO set to become chairman; dividend date looms

New York, Feb 6, 2026, 12:34 PM EST — Regular session.

Shares of Amphenol Corp jumped nearly 8% to $137.90 in midday trading Friday, far outstripping the broader U.S. market rally. The S&P 500’s SPY ETF climbed roughly 1.6%, while the Nasdaq 100’s QQQ advanced around 1.9%.

The rebound follows a tough stretch for the interconnect maker, whose shares dropped 1.8% Thursday to close at $127.63 amid a broader market selloff. Amphenol remains far off its January 27 peak of $167.04, and Thursday’s volume spiked well above its 50-day average, indicating unsettled investor sentiment. 1

Governance changes are underway at Amphenol. The board has named President and CEO R. Adam Norwitt as chairman, effective at the annual meeting slated for May. Long-serving chairman Martin H. Loeffler is set to retire from the board. “The decision to appoint Adam … reflects the Board’s confidence,” said lead independent director David P. Falck. 2

A regulatory filing confirmed Loeffler’s retirement isn’t due to any dispute over the company’s operations, policies, or practices. 3

For investors, the leadership shuffle adds another factor to consider after a rapid climb followed by a steep drop. Merging the CEO and chair positions might not raise eyebrows for some, but for others, it’s a red flag—especially depending on how the board enforces checks and balances.

An executive trade popped up on the tape as well. According to a Form 4 filing, vice president and corporate controller Michael Ivas exercised options for 25,000 shares on Feb. 4. He also gifted 25,000 shares that same day. 4

The day’s action is also fueled by tape momentum. As major indexes push higher, investors are snapping up battered industrial tech and data-center-related suppliers. Amphenol typically moves along with that sector when risk appetite picks up.

Yet the rally could reverse fast if the broader upswing stalls. Governance shifts—even those already on the roadmap—often spark fresh scrutiny when a stock is already volatile.

Amphenol plans to pay a $0.25 quarterly dividend on April 14, targeting shareholders recorded by March 23. 5

Stock Market Today

  • Regeneron Pharmaceuticals (REGN) Seen as Undervalued Amid Recent Price Pullback
    February 6, 2026, 1:07 PM EST. Regeneron Pharmaceuticals (REGN) has experienced a recent pullback, with its share price falling about 1% in one day and 5.6% over the past month. Yet, the stock maintains a 16.6% gain over three months and a strong 58.7% total return over five years. Trading near $766.63, REGN is valued below the fair value estimate of $821 per share, based on expected revenue growth, firm margins, and pipeline progress in immunology, oncology, and genetic medicines. Analysts highlight Regeneron's solid pipeline, including advances in Lynozyfic and odronextamab, suggesting potential earnings upside backed by demographic demand and precision medicine trends. The stock's discount may reflect market expectations, but the 7% discount rate and anticipated share count reductions support a cautiously optimistic outlook for investors.
Mastercard stock slides even as Wall Street rises after new SEC filing and global deal push
Previous Story

Mastercard stock slides even as Wall Street rises after new SEC filing and global deal push

Go toTop